Luramax 20 Tablet contains Lurasidone 20 mg, an atypical antipsychotic indicated for the treatment of schizophrenia and bipolar depression. Lurasidone exerts its therapeutic effects primarily through antagonism of dopamine D2 and serotonin 5-HT2A receptors, which helps in modulating neurotransmitter activity implicated in psychotic and mood disorders. It is effective in reducing symptoms such as hallucinations, delusions, mood swings, and cognitive disturbances associated with these conditions. Luramax 20 is typically administered orally once daily, with or without food, and dosage adjustments may be necessary based on clinical response and tolerability. Common adverse effects include nausea, somnolence, akathisia, and extrapyramidal symptoms, while serious side effects may involve metabolic changes, tardive dyskinesia, and neuroleptic malignant syndrome. Regular monitoring of metabolic parameters, including blood glucose and lipid profile, is recommended during treatment. Lurasidone should be used cautiously in patients with a history of cardiovascular disease, seizures, or hepatic impairment. It is contraindicated in individuals with known hypersensitivity to the drug. Luramax 20 should be prescribed and administered under the supervision of a qualified healthcare professional, with careful consideration of benefits versus risks for each patient.